| scholarly article | Q13442814 |
| P50 | author | Elizabeth Hatch | Q43148948 |
| Julie R Palmer | Q47709111 | ||
| Lynn Rosenberg | Q55454936 | ||
| Deborah A Boggs | Q114406874 | ||
| Jaclyn L F Bosco | Q117269059 | ||
| P2860 | cites work | Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors | Q25257303 |
| Association between frequent use of nonsteroidal anti-inflammatory drugs and breast cancer | Q25257496 | ||
| Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative | Q28165551 | ||
| Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk | Q28168742 | ||
| Aspirin and breast cancer prevention: the estrogen connection | Q28168745 | ||
| Risk of breast cancer among users of aspirin and other anti-inflammatory drugs | Q28169157 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status | Q28176257 | ||
| Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial | Q28182721 | ||
| Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues | Q28192400 | ||
| Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer | Q28194496 | ||
| Aspirin and cancer risk: an updated quantitative review to 2005 | Q28199522 | ||
| Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort | Q28213690 | ||
| NSAID use and breast cancer risk in the VITAL cohort | Q28219138 | ||
| Nonsteroidal antiinflammatory drugs and breast cancer risk: the multiethnic cohort | Q28219482 | ||
| Alcohol and cancer | Q28295240 | ||
| Mechanism of action of paracetamol | Q28303483 | ||
| Analgesic use and sex steroid hormone concentrations in postmenopausal women | Q33780860 | ||
| Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study | Q33889458 | ||
| New insights into the mechanism of action of acetaminophen: Its clinical pharmacologic characteristics reflect its inhibition of the two prostaglandin H2 synthases | Q33992920 | ||
| Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study | Q34069337 | ||
| Paracetamol (Acetaminophen): mechanisms of action | Q34834887 | ||
| Breast cancer and obesity: an update | Q35147502 | ||
| Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial | Q36494133 | ||
| Physical activity and breast cancer: a systematic review. | Q36666202 | ||
| Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study | Q36678729 | ||
| Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II | Q37077094 | ||
| Association between acetaminophen or nonsteroidal antiinflammatory drugs and risk of developing ovarian, breast, or colon cancer | Q38490106 | ||
| Breast cancer: magnitude of the problem and descriptive epidemiology | Q39127800 | ||
| Breast cancer epidemiology: summary and future directions | Q39410599 | ||
| Cyclooxygenase inhibitors suppress aromatase expression and activity in breast cancer cells. | Q40462696 | ||
| Association between non-steroidal anti-inflammatory drugs (NSAIDs) and invasive breast cancer and carcinoma in situ of the breast | Q40534891 | ||
| Reproductive factors and breast cancer | Q40862181 | ||
| Prospective study of regular aspirin use and the risk of breast cancer | Q41007088 | ||
| Aspirin use and risk of fatal cancer | Q41085386 | ||
| A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. | Q41145531 | ||
| Modulation of breast cancer risk by nonsteroidal anti-inflammatory drugs. | Q43061636 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer | Q44182615 | ||
| Nonsteroidal anti-inflammatory drug use and breast cancer risk: a Danish cohort study | Q46743593 | ||
| Height and breast cancer risk: results from the Black Women's Health Study (United States). | Q46929792 | ||
| Nonsteroidal antiinflammatory drug use and reduced risk of large bowel carcinoma. | Q50881116 | ||
| Issues to debate on the Women's Health Initiative (WHI) study. Epidemiology or randomized clinical trials--time out for hormone replacement therapy studies? | Q52956342 | ||
| The Relationship of Nonsteroidal Anti-inflammatory Drug Use to the Risk of Breast Cancer | Q59763658 | ||
| Breast Cancer and NSAID Use: Heterogeneity of Effect in a Case-Control Study | Q71836037 | ||
| Aspirin use and lung, colon, and breast cancer incidence in a prospective study | Q72397360 | ||
| Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer | Q74376052 | ||
| Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD | Q79852024 | ||
| P433 | issue | 11 | |
| P921 | main subject | aspirin | Q18216 |
| breast cancer | Q128581 | ||
| P1104 | number of pages | 9 | |
| P304 | page(s) | 1553-1561 | |
| P577 | publication date | 2011-08-30 | |
| P1433 | published in | Cancer Causes & Control | Q325957 |
| P1476 | title | Regular aspirin use and breast cancer risk in US Black women | |
| P478 | volume | 22 |
| Q41093416 | Aspirin as a potential modality for the chemoprevention of breast cancer: A dose-response meta-analysis of cohort studies from 857,831 participants. |
| Q55312563 | Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies. |
| Q26827455 | Can Aspirin and Cancer Prevention be Ageless Companions? |
| Q59135502 | Celecoxib in breast cancer prevention and therapy |
| Q30367680 | Cyclooxygenase-2 and the inflammogenesis of breast cancer. |
| Q34458235 | Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. |
| Q35870384 | Lifetime use of nonsteroidal anti-inflammatory drugs and breast cancer risk: results from a prospective study of women with a sister with breast cancer |
| Q33619700 | Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study |
| Q38786791 | The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future Perspectives |
| Q44640097 | Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population |
| Q28075857 | Use of acetaminophen in relation to the occurrence of cancer: a review of epidemiologic studies |
| Q36267669 | Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence |
Search more.